Alpha Cognition Inc
ACOG
Classement en actions
#20068
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Prix de l'action
$8.66
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$134.50M
Changement (1 jour)
1.88%
Changement (1 an)
72.17%
Pays
US
Échange Alpha Cognition Inc (ACOG)
Catégorie
Healthcare
Historique des divisions d’actions pour Alpha Cognition Inc (ACOG)
L’action Alpha Cognition Inc (symbole : ACOG) a subi un total de 1 divisions.
La division la plus récente a eu lieu le Nov 05, 2024.
Une action ACOG achetée avant le Nov 05, 2024 équivaudrait aujourd’hui à 0.04 actions ACOG.
La division la plus récente a eu lieu le Nov 05, 2024.
Une action ACOG achetée avant le Nov 05, 2024 équivaudrait aujourd’hui à 0.04 actions ACOG.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| 2024-11-05 | 1:25 | x0.04 | x0.04 |
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
